Ghrelin modulates intracellular signalling pathways that are critical for podocyte survival

Damage to podocytes is a key event in glomerulopathies. While energy dense food can contribute to kidney damage, the role of the orixegenic hormone “ghrelin” in podocyte biology is still unknown. In the present study, we investigated the effect of ghrelin on podocyte survival as well as the signalli...

Full description

Saved in:
Bibliographic Details
Main Author: El Zein, Nabil (author)
Other Authors: Abdallah, Maya S. (author), Daher, Costantine F. (author), Mroueh, Mohammad (author), Stephan, Joseph (author), Bahous, Sola Aoun (author), Eid, Assaad (author), Faour, Wissam H. (author)
Format: article
Published: 2019
Online Access:http://hdl.handle.net/10725/10913
https://doi.org/10.1002/cbf.3397
http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php
https://onlinelibrary.wiley.com/doi/full/10.1002/cbf.3397
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Damage to podocytes is a key event in glomerulopathies. While energy dense food can contribute to kidney damage, the role of the orixegenic hormone “ghrelin” in podocyte biology is still unknown. In the present study, we investigated the effect of ghrelin on podocyte survival as well as the signalling pathways mediating ghrelin effect in immortalized cultured rat podocytes. RT‐PCR analysis revealed that GHS‐R1 is expressed in rat podocytes. Western blot analysis showed that ghrelin upregulated COX‐2 protein expression in a time and dose‐dependent manner. Additionally, ghrelin activated P38 MAPK, AKT, and ERK1/2 pathways and also induced P38 MAPK phosphorylation in high glucose conditions. Ghrelin induced ROS release and dose dependently reduced podocyte survival. Ghrelin mediated podocyte cell death was partially reversed by pharmacologically inhibiting P38 MAPK or phospholipase C (PLC). Furthermore, PLC inhibitor (U73122) inhibited ghrelin induced P38 MAPK activation. While PI3K inhibitor (LY294002) was without effect on cell survival or P38 MAPK activation, it inhibited ghrelin induced ERK1/2 phosphorylation. Finally, ghrelin induced TAU phosphorylation was reversed by pharmacologic inhibitors of either P38 MAPK or PKA. In conclusion, ghrelin activated harmful molecular pathways in podocytes that can be damaging to the glomerular filtration barrier